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Sheffield Teaching Hospitals NHS Trust, Sheffield, UKTwo large trials (NASCET and ECST) have shown
carotid endarterectomy (CEA) reduces the risk of
cerebral infarction in patients with a recently
symptomatic (!6 months), severe (50–99%) stenosis
of the ipsilateral internal carotid artery.1,2 The
original analyses suggested that the degree of benefit
gained was related, in part at least, to the severity of
the stenosis. Subsequent analysis of the pooled data
on 5893 patients has shown that the benefit from
surgery was greatest in men (pZ0.003), those over
the age of 75 years (pZ0.03) and those randomised
within 2 weeks after their last ischaemic event (pZ
0.009).3 The only large trial of endovascular inter-
vention versus (angioplasty or stenting) has shown
no difference in early or late outcomes in the 504
randomised patients4 and a larger international trial
(ICSS) is now underway.5
There remains a question as to whether carotid
intervention (CEA or stenting) should be performed
as an emergency, within hours or days after onset of
ischaemic stroke, as the risk of a further stroke has
been shown to fall exponentially with time. Early
studies showed that emergency CEA carried a high
risk of cerebral haemorrhage and that the risk of
stroke or death in patients with unstable neurologi-
cal symptoms was about 20%.6 Whilst there is no
evidence that early surgery (within a week) after
stroke in patients who are neurologically stable is
associated with increased operative risk7 there is
little evidence to suggest that there is any benefit in
reducing early stroke recurrence and current avail-
able evidence would support a policy of immediate
medical therapy, i.e. antiplatelet agents followed bying author. Mr Marc Randall, Department of Neurol-
allamshire Hospital, Sheffield S10 2JF, UK.
: marc.randall@sth.nhs.uk
0614 + 03 $35.00/0carotid intervention as soon as patients have
achieved independence.
The use of antiplatelet drugs (aspirin) in the acute
setting has been well validated by both the
International Stroke Trial (IST), and the Chinese
Acute Stroke Trial (CAST) using slightly differing
treatment regimes.8,9 The IST collaborators used
300 mg of aspirin for 2 weeks, or until discharge,
and the Chinese study used 160 mg in the acute
phase for 4 weeks.
Hypertension, particularly accelerated or malignant
hypertension after acute cerebral infarction is likely to
increase the risks associated with early carotid
intervention as in the post operative period it is
associated with hyperperfusion syndrome. Tight
blood pressure control pre operatively conflicts with
current American and European post stroke rec-
ommendations for blood pressure control which
suggest avoidance of artificial blood pressure lowering
in the acute stroke period.10 This issue of artificial
blood pressure reduction is currently the subject of
several randomised controlled trials and until the
results of these trials is available extreme caution with
blood pressure alteration in the acute stroke period
must be advised.
The place of statin therapy in the acute stroke
remains unclear at this time. The Heart Protection
Study (HPS) has demonstrated clear benefits in
secondary prevention, and a statin at the highest
tolerated daily dose should probably be prescribed for
all patients with vascular disease, irrespective of their
total cholesterol.11
Angiographic studies within 6 h of stroke demon-
strate that 75–89% of patients with an acute ischaemic
stroke have a visible occlusion of an extracranial
and/or intracranial artery related to the ischaemic
area. In the majority of cases this occlusion will be ofEur J Vasc Endovasc Surg 30, 614–616 (2005)
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artery due to distal embolisation of thrombus from the
internal carotid. The aim of early surgical revascular-
isation in patients with carotid stenosis is to prevent
early stroke recurrence due to further embolisation
from a stenosed ulcerated plaque, however there are
no randomised trials in patients with stroke secondary
to carotid occlusion in whom the aim would be to
reduce the area of irreversible cerebral ischaemia by
enhancing reperfusion. These patients are ideally
treated with systemic agents either intravenous or
intra arterial.
Meta-analysis of the randomised trials of intrave-
nous thrombolysis (2775 patients) with recombinant
tissue plasminogen activator (rt-PA) has shown that
treatment started within 3 h leads to fewer depen-
dent patients at 3 months.12 These findings have now
also been confirmed outside of the trial setting.13 The
benefits of thrombolysis after 3 h may be outweighed
by the risk of cerebral haemorrhage (5%) but remain
unclear and are currently the subject of two
randomised controlled trials looking at up to 4.5 h
(ECASS III) and 6 h (IST3). Intra-arterial thrombolysis
probably results in quicker and better recanalisation
rates14 but this benefit likely to be offset by the delays
incurred in performing selective carotid catheterisa-
tion and a higher risk of cerebral haemorrhage (10%).
It has been suggested that mechanical clot disrup-
tion15 or aspiration16 might shorten the time to flow
restoration, and improve overall recanalisation rates,
but the data on this is confined to single reports or
small case series. In the small number of patients
with poor collateral flow acute carotid occlusion may
result in stroke without any distal embolisation. A
small case series using angiograpic thrombolysis and
immediate surgery has shown some success in these
patients.17 Emergency carotid thromboembolectomy
may also produce high recanalisation rates of over
80%18 but again, any benefits are likely to be offset by
the delays incurred in performing emergency
surgery.
In summary, the pragmatic management of patients
with stroke is to start intravenous thrombolysis in
those who can be treated up to 3 h after onset of
symptoms only after performing a CT head scan to
exclude cerebral haemorrhage. Patients who cannot be
treated under 3 h under the present licence for tPA and
those presenting between 3 and 6 h of onset of
symptoms should be included in current randomised
trials e.g. IST3 (www.IST3.com)
Patients who improve and achieve independence
(i.e. a Modified Oxford Handicap Score of three or less)
require early investigation as to the cause of their
stroke and if carotid imaging suggests a significantipsilateral carotid stenosis then intervention (CEA or
stenting) can and should be performed sooner rather
than later in addition to the medical therapy already
outlined. Carotid stenting should only be performed
as part of a randomised trial in comparison with CEA.
There is no evidence to support emergency carotid
intervention at this time.References
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